Research
RIH runs projects on the production of radionuclides, chemical separation and labeling, nuclear spectroscopy, targeting (imaging, therapy), chemical speciation, radiometalloproteomics, metal toxicity, assessment of radiation dose, and trace element research on distribution, pathways, speciation and monitoring, the latter all mostly focused on reaction kinetics and process dynamics.
Current key projects:
- Development of radioisotope carriers
- Production of carrier-free radionuclides
- 3Binding
- (Bis)phosphate complexes for treatment of bone metastases
- Szilard & Chalmers production of 99Mo-99mTc
- New routes for the production of Re-186
- Alpha-particle therapy
- Medical applications of nano-materials
- Lipid-based nano-materials with tumor-specific peptides
- Toxicity of mixtures of metals
- Side effects of medical nano-materials
- Radio-analysis
- Radioactivity in excreta from radiotherapy patients
- Kinetic stability of Pt-complex-DNA adducts
- Stability kinetics on ML, MHL and MH2L complexes of 177Lu-DOTA-octreotate
- PAC spectroscopy
- Proton beam therapy
- Liver biopsies in studies with companion animals
- Optimization of sample collection in health-oriented studies
- A decision support system for granular material in
radiopharmaceutical industry and food industr - Urine and faeces in diapers of babies and elderly people
- Toe-nail clippings
Research in RIH is sponsored by:
|
Technology Foundation |
|
| NUTS-OHRA |
|
| IAEA |
|
| Ministry of Economic Affairs |
|
| World Cancer Research Fund |
|
| IUPAC |
|
| Insituto Tecnológico e Nuclear |
|
| URENCO |
|
| Covidien |
|
| EU Marie Curie |
|
| Nutreco |
|
| Schering-Plough/Organon |
|
| Hosokawa |
|
| TNO and CIVO-TNO |
|
| NFI |
|
| Cardialysis |
|
| Cyclotron Amsterdam |
|
| MiLabs BV |
|
Last edited: 09 February 2010
Author name: T.G. Verburg